A set of three volumes (3,100 pages) with a description of 870 products, together with a comprehensive profile of 340 companies active around the world in.
(0)
BRUSSELS, Belgium and MELBOURNE, Australia, April 20, 2021 (GLOBE NEWSWIRE) The Oncidium Foundation, a non-profit organisation created to promote and support the development of radiopharmaceuticals for better patient access, and Telix Pharmaceuticals Limited ( Telix ), a radiopharmaceutical company developing diagnostic and therapeutic products ( theranostics ) using Molecularly Targeted Radiation (MTR), are pleased to announce the launch of the NOBLE Registry, an international clinical collaboration for the development of
99mTc-iPSMA SPECT imaging for prostate cancer, and the dosing of the first patient at the University College Hospital, Ibadan, Nigeria.
Prostate cancer is the second most frequent cancer diagnosis in men and the fifth leading cause of cancer death worldwide
The NOBLE Registry – An International Collaboration to Develop iPSMA SPECT Imaging for Prostate Cancer streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.